journal article·2026-08

A water-soluble and near-infrared indomethacin-modified BODIPY photosensitizer for tumor-targeting photodynamic therapy

Lixia Bai, Xingcan Li, Lifei Chen, Yicheng Wang, Huijuan Zhang, Zhen Li, Xiaoxing Xiong, Hongping Deng, Wing-Leung Wong, Shaoqing Zhuang, Chunya Li

Dyes and Pigments· Volume 251
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Cancer statistics
2. Cancer statistics
3. Lung cancer immunotherapy: progress, pitfalls, and promises10.1186/s12943-023-01740-y ↗
4. Global research trends on Chinese patent drugs inducing programmed cell death in cancer: a bibliometric analysis (1998-2024)10.1007/s12672-025-02913-5 ↗
5. Nanomaterials in tumor immunotherapy: new strategies and challenges10.1186/s12943-023-01797-9 ↗
6. Tumor microenvironment
7. Editorial: drug repurposing for cancer treatment: current and future directions10.3389/fonc.2025.1550672 ↗
8. Emerging nanotechnology and advanced materials for cancer radiation therapy10.1002/adma.201700996 ↗
9. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
10. Manganese-based Tumor immunotherapy
11. Heterostructural nanoadjuvant CuSe/CoSe2 for potentiating ferroptosis and photoimmunotherapy through intratumoral blocked lactate efflux10.1021/jacs.2c12772 ↗
12. Orchestrating nitric oxide and carbon monoxide signaling molecules for synergistic treatment of MRSA infections
13. Luminescent quantum dots: synthesis, optical properties, bioimaging and toxicity10.1016/j.addr.2023.114830 ↗
14. Chemodynamic therapy via Fenton and Fenton-like nanomaterials: strategies and recent advances10.1002/smll.202103868 ↗
15. Clinical trials update in the photodynamic therapy strategy for treatment of choroidal melanoma: a review of literature10.1016/j.pdpdt.2025.104521 ↗
16. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
17. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
18. Tumor microenvironment as a therapeutic target in cancer10.1016/j.pharmthera.2020.107753 ↗
19. Tumor-microenvironment-responsive Cascade reactions by a cobalt-single-atom nanozyme for synergistic nanocatalytic chemotherapy10.1002/anie.202204502 ↗
20. The evolving tumor microenvironment From cancer initiation to metastatic outgrowth10.1016/j.ccell.2023.02.016 ↗
21. Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy10.1038/s41467-021-23194-w ↗
22. Recent advances in fluorescent probes for cancer biomarker detection10.3390/molecules29051168 ↗
23. An enzyme-free and label-free ratiometric fluorescence signal amplification biosensor based on DNA-silver nanoclusters and catalytic hairpin assembly for tetracycline detection10.1016/j.snb.2023.135216 ↗
24. Activatable NIR-II organic fluorescent probes for bioimaging10.7150/thno.71359 ↗
25. Nanoscale photosensitizer with tumor-selective turn-on fluorescence and activatable photodynamic therapy treatment for COX-2 overexpressed cancer cells10.1039/D0TB02828B ↗
26. Platinum prodrug nanoparticles with COX-2 inhibition amplify pyroptosis for enhanced chemotherapy and immune activation of pancreatic cancer
27. Indomethacin-based near-infrared photosensitizer for targeted photodynamic cancer therapy10.1016/j.bioorg.2022.105758 ↗
28. COX-2-targeted fluorescent probe for ClO- monitoring in precise cancer detection10.1016/j.bioorg.2025.108164 ↗
29. COX-2 targeting and hypoxia activation of IMC-NTR for cancer diagnosis and therapeutics: in vitro and in vivo studies10.1016/j.snb.2025.137970 ↗
30. BODIPY conjugates with monoterpenoids for photodynamic diagnostics and therapy: design, spectral properties, photostability and antifungal activity10.1016/j.jphotochem.2025.116611 ↗
31. Molecular design of Monochromophore-Based bifunctional photosensitizers for simultaneous ratiometric oxygen reporting and photodynamic cancer therapy10.1021/acs.analchem.1c02485 ↗
32. Recent advances in targeting COX-2 for cancer therapy: a review10.1039/D5MD00196J ↗
33. Strategic functionalization of bromine and nitrogen at the bay region of perylene induces a heavy atom effect and promotes intersystem crossing10.1039/D5CP03115J ↗
34. Poly(photosensitizer) nanoparticles for enhanced in vivo photodynamic therapy by interrupting the π–π stacking and extending circulation time10.1021/acsami.9b04351 ↗
35. The Golgi apparatus as a strategic target in cancer: mechanisms, diagnosis and therapeutic opportunities10.1080/1061186X.2025.2527867 ↗
36. Albumin-based multidrug delivery system enriched in Golgi apparatus against metastatic breast cancer10.1007/s12274-022-5141-5 ↗
37. COX-2 inhibition mediated aggregation-induced emission photosensitizer target the Golgi apparatus for selective imaging of cancer cells and enhanced photodynamic therapy10.1016/j.dyepig.2023.111897 ↗
38. Cyclooxygenase-2-targeting fluorescent carbon dots for the selective imaging of Golgi apparatus10.1016/j.dyepig.2022.110213 ↗
39. A Nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-210.1039/C4CC08915D ↗
40. Aza-BODIPY probe for selective visualization of cyclooxygenase-2 in cancer cells10.1039/C9RA01948K ↗
41. The role of ROS in tumour development and progression10.1038/s41568-021-00435-0 ↗